Academic Journals Database
Disseminating quality controlled scientific knowledge

Secondary Causes of Low Bone Mineral Density in Breast Cancer Patients: An Update

Author(s): Y Chiu Kang | Julie A Miller | G Bruce Mann

Journal: European Journal of Clinical & Medical Oncology
ISSN 1759-8958

Volume: 2;
Issue: 2;
Start page: 35;
Date: 2010;
VIEW PDF   PDF DOWNLOAD PDF   Download PDF Original page

Keywords: breast cancer | bone mineral density | aromatase inhibitor | vitamin D | hyperparathyroidism

Bone health has become increasingly important in the management of early breast cancer. The reasons for this include the general recognition of post-menopausal osteoporosis as an important health issue, the long survival of most women diagnosed with breast cancer, and the impact of treatments, especially the aromatase inhibitors, on bone density. Algorithms and guidelines for managing these issues have mainly focused on detecting low bone mineral density and treating it. New evidence has emerged suggesting that secondary causes of low bone mineral density are common and a significant problem for breast cancer survivors. This article reviews recent studies and suggests ways of incorporating these new data into practice.
RPA Switzerland

RPA Switzerland

Robotic process automation


Tango Jona
Tangokurs Rapperswil-Jona